CNXCConcentrix Corporation

$27.85

CNXC as reported

Concentrix Corporation reported $10.00B of revenue over the trailing twelve months, +3.9% on the year before. 11 reported series are charted on this page, each one as filed.

$10.00B

Revenue, trailing twelve months · to Q2 2026 · +3.9% against the twelve months before

Net Income
−$1.31B

Net Income · −637% year on year · trailing twelve months to Q2 2026

Free Cash Flow
$514M

Free Cash Flow · +5.9% year on year · trailing twelve months to Q2 2026

Op Margin
−9.9%

Op Margin · trailing twelve months to Q2 2026

Every series Ryufin has for CNXC, trailing twelve months
SeriesLatestYear on yearAs of
Revenue$10.00B+3.9%Q2 2026
Net Income−$1.31B−637%Q2 2026
EPS−$20.84−674%Q2 2026
Gross Margin34%n/aQ2 2026
Op Margin−9.9%n/aQ2 2026
Net Margin−13%n/aQ2 2026
ROE−34%n/aQ2 2026
ROA−8.6%n/aQ2 2026
ROIC−6.7%n/aQ2 2026
Free Cash Flow$514M+5.9%Q2 2026
P/E12.0n/aQ3 2025

Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.

Revenue & ProfitConcentrix Corporation (CNXC)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com